Holmusk
Highly Engaged Employees
Healthcare Software · Singapore · 51-200 Employees
View Company Info for Free
Overview
Headquarters
71 Ayer Rajah Cres 06-09, Singapore, Cen...Phone Number
+65 62504233Website
www.holmusk.comRevenue
$21 MillionIndustry
About Holmusk
Holmusk Org Chart
Is Holmusk your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Holmusk had a recent Job posting/layoffs
Holmusk, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Holmusk has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Holmusk
Earning: See what the market has to say on Holmusk recently announced quarterly report
Product Launch: Get notified when Holmusk launches new products
Check out if Holmusk is spiking on competitors!
Funding: Get notified immidiatlly once Holmusk has new funding data
Recommended Actions
Find VP level buyers at Holmusk
Find 3 more new buyers
Company Profile Activity
Activity Insights
Holmusk is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Holmusk is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Holmusk.
Holmusk financials insights
Gather financial insights about Holmusk, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$9.8M
Series A
$21.5M
Series B
$45M
Holmusk Tech Stack
A closer look at the technologies used by Holmusk
Most Recent Scoops
Holmusk News & Media
Holmusk Expands NeuroBlu to 46 Million Patients, Adding Depth and Biomarker Data Across Neurology and Behavioral Health
Expansion anchored by two top neurological health systems, structured AD biomarker data, and validated outcomes measures across neurological disease areas. Whole-population ingestion shifts NeuroBlu from patient counts to research-grade signal. NEW YORK, May 29, 2026 /PRNewswire/ --...Iris Telehealth and Holmusk Announce Strategic Partnership to Advance Data-Driven Mental Health Care
Holmusk's NeuroBlu Platform and Iris Insights: Powering Real-World Evidence to Deliver Patient Outcomes and Value-Based Care AUSTIN, Texas, June 4, 2025 /PRNewswire/ -- Iris Telehealth, a leading provider of telepsychiatry services, and Holmusk, a global leader in real-world evidence and...NeuroBlu: New Data Partner and Enterprise SSO Integration
Major expansion of behavioral health data with 940K+ new patient records, enterprise SSO integration, and enhanced analytics tools for deeper research insights. NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Holmusk, a global leader in behavioral health real-world evidence, today announced the release of NeuroBlu Analytics v4.6, a major platform upgrade that combines expanded data coverage, enhanced analytics capabilities, and improved enterprise security through single sign-on (SSO) integration. This lHolmusk and Veradigm Reach New Data Enrichment Milestone in Strategic Collaboration
Veradigm Network EHR data enables a deeper understanding of the patient journey and disorder progression NEW YORK and CHICAGO, July 24, 2024 /PRNewswire/ -- Holmusk, a leading global mental health real-world evidence company, and Veradigm® (OTCMKTS: MDRX), a leading healthcare data and...
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Holmusk
Founded in 2015, Holmusk is a digital health and data science company which has developed a Real World Evidence (RWE) platform in neuroscience and for chronic diseases. Holmusk's proprietary modeling platform leverages scientific research and digital healthcare data to inform predictive algorithms and provide actionable insights for personalized me... Read More